1-7 of 7
patient counseling
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocyteic Leukemia Patients Who Underwent Reduced Intensity Conditioning Allogeneit HCT: A CIBMTR Report

Haesook T Kim, PhD, Zhen-Huan Hu, MPH, Kwang Woo Ahn, PhD, Matthew Davids, MD, Virginia Volpe, MD, Edwin Alyea, MD, Uday Popat, MD, Ronald Sobecks, MD, Wael Saber, MD MS, Jennifer Brownn, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 667.
https://doi.org/10.1182/blood.V130.Suppl_1.667.667
Published: 2017
Journal Articles

Counseling Patients (pts) with Higher-Risk Myelodysplastic Syndromes (HR-MDS) Regarding Expected Survival with Azacitidine (aza) Therapy: Are We Using Accurate Estimates?

Michelle Deveaux, Maximilian Stahl, MD, Smith Giri, MBBS, Rong Wang, PhD, Nikolai A. Podoltsev, MD PhD, Xiaomei Ma, MD PhD, Amer M. Zeidan, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2114.
https://doi.org/10.1182/blood.V130.Suppl_1.2114.2114
Published: 2017
Journal Articles

A Quality Improvement Initiative Advancing CLL Care Practices across Four US Health Systems

Matthew S. Davids, MD, Anthony R. Mato, MD, John M. Pagel, MD PhD, Thomas Lad, MD, James J.L. Mateka, MS, Cherilyn Heggen, PhD, Jeffrey D Carter, PhD, Tamar Sapir, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2124.
https://doi.org/10.1182/blood.V130.Suppl_1.2124.2124
Published: 2017
Journal Articles

Comorbidity Index (CI) in Autologous Hematopoietic Cell Transplantation (HCT) for Malignant Diseases: Validation of the HCT-CI

Marcelo C. Pasquini, MD, MS, Brent R. Logan, PhD, Vincent T Ho, MD, Philip L. McCarthy, Jr., MD, Kenneth R. Cooke, MD, J. Douglas Rizzo, MD, Xiaochun Zhu, MS, Mohamed L. Sorror, MD, MSc
Journal: Blood
Blood (2012) 120 (21): 814.
https://doi.org/10.1182/blood.V120.21.814.814
Published: 2012
Journal Articles

The Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Can Prospectively Discriminate Risks Affecting Overall Survival in Pediatric and Adult Patients with Non-Malignant Diseases

Monica S Thakar, MD, Brent R. Logan, PhD, Marcelo C. Pasquini, MD, MS, Philip L. McCarthy, Jr., MD, Vincent T Ho, MD, Kenneth R. Cooke, MD, Xiaochun Zhu, MS, J. Douglas Rizzo, MD, Mohamed L. Sorror, MD, MSc
Journal: Blood
Blood (2012) 120 (21): 737.
https://doi.org/10.1182/blood.V120.21.737.737
Published: 2012
Journal Articles

The HCT-Specific Comorbidity Index Fails to Predict Survival After Allogeneic HCT In High Risk AML Patients - A Single Center Experience

Nicole Birninger, Martin Bornhàˆuser, Martin Wermke, Stefani Parmentier, Brigitte Mohr, Christoph Ròˆllig, Uwe Platzbecker, Gerhard Ehninger, Johannes Schetelig
Journal: Blood
Blood (2010) 116 (21): 1326.
https://doi.org/10.1182/blood.V116.21.1326.1326
Published: 2010
Journal Articles

Weighted Prognostic Models for Survival in Untreated and Previously Treated Patients with CLL.

William G. Wierda, MD, PhD, S. OBrien, MD, X. Wang, MS, A. Ferrajoli, MD, S. Faderl, MD, D. Thomas, MD, F. Ravandi, MD, K. Do, PhD, H. Kantarjian, MD, S. Lerner, MS, M. Keating, MD
Journal: Blood
Blood (2005) 106 (11): 5012.
https://doi.org/10.1182/blood.V106.11.5012.5012
Published: 2005